Approval · Notice of Compliance 90 · 2004
FACTIVE: Notice of Compliance 90
Issued March 9, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 90
- Date
- March 9, 2004
- Company
- Lg Life Sciences Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FACTIVE | 02248968 | Cancelled Post Market |
Medicinal ingredients
- GEMIFLOXACIN MESYLATE 320 MG per TAB